Japan nation-wide registry for Metastatic castration-resistant prostate cancer with BOne metastasis(JMBO) - JMBO study

The Japanese Urological Association0 个研究点目标入组 300 人开始时间: 2018年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1 Prior chemotherapy after dignosis of CRPC(except for UFT or EMT) 2 Prior hemibody extemal radiotherapy 3 Prior treatment with Stontium-89 for bone metastasis within 24 weeks from enrollment 4 Prior treatment with radium-223 5 Has history of gastrointestenal bleeding prior study entry 6 Any active other malignancy 7 History of visceral metastasis or presence of visceral metastasis detected by screening imaging examinations 8 History of or known brain metastasis 9 Malignant lymphadenopathy exceeding 3cm in shortaxis diameter 10 Imminent or established spinal cord compression based on clinical findings and/or MRI(Magnetic Resonance Imaging) 11 Any other serious illness or medical condition 12 Substance abuse,medical,psychological,or social conditions that may interfere with the subject's participation in the study or evaluation of the study results

发起方

The Japanese Urological Association